Conclusion
Our study suggests that FT3 levels at admission are significantly and
independently associated with risk of poor outcome after ischemic stroke
and lower FT3 levels can be regarded as a prognostic biomarker for poor
outcome at 3 months.
Keywords: Acute ischemic stroke, Thyroid hormones, Free
triiodothyronine, Functional outcome